The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The Implications of Choice: Prescribing Generic or Preferred Pharmaceuticals Improves Medication Adherence for Chronic Conditions
Abstract
BACKGROUND: A large proportion of Americans are enrolled in 3-tier pharmacy benefit plans. We studied whether patients enrolled in such plans who receive generic or preferred brand-name agents when initiating chronic therapy were more adherent to treatment than those who received nonpreferred brand-name medications. METHODS: We analyzed pharmacy claims filled between October 1, 2001, and October 1, 2003, from a large health plan for 6 classes of chronic medications: 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, calcium channel blockers, oral contraceptives, orally inhaled corticosteroids, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors. We measured adherence as the proportion of days covered (PDC) in each drug class during the first year of therapy. We evaluated how the formulary status of the initial prescription (generic, preferred, or nonpreferred) influenced PDC and adequate adherence, defined as PDC greater than 80%, over the subsequent year. RESULTS: A total of 7532 new prescriptions were filled in 1 of the classes evaluated: 1747 (23.2%) for nonpreferred medications, 4376 (58.1%) for preferred drugs, and 1409 (18.7%) for generic drugs. After controlling for patient sociodemographic characteristics and drug class, PDC was 12.6% greater for patients initiated on generic medications vs nonpreferred medications (58.8% vs 52.2%; P<.001). The PDC was 8.8% greater for patients initiated on preferred vs nonpreferred medications (56.8% vs 52.2%; P<.001). Patients initiated on generic and preferred medications had 62% and 30% greater odds, respectively, of achieving adequate adherence compared with those who received nonpreferred medications. CONCLUSION: In 3-tier pharmacy benefit plans, prescribing generic or preferred medications within a therapeutic class is associated with improvements in adherence to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
Persistence of Use of Lipid-Lowering Medications: A Cross-National Study
Avorn, J., Monette, J., Lacour, A., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998) · JAMA · doi:10.1001/jama.279.18.1458 · Cited by 634
Self-citationHinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., & Stefaniak, M. (2004) · AIDS · doi:10.1097/00002030-200418001-00004 · Cited by 551
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Goldman, D. P. (2004) · JAMA · doi:10.1001/jama.291.19.2344 · Cited by 530
Geronimus, A. T., & Bound, J. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009673 · Cited by 485
Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons
Rosenberg, M. J., & Waugh, M. S. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70047-x · Cited by 435
Patient-Physician Communication About Out-of-Pocket Costs
Alexander, G. C. (2003) · JAMA · doi:10.1001/jama.290.7.953 · Cited by 414
Adherence with Twice-daily Dosing of Inhaled Steroids: Socioeconomic and Health-belief Differences
APTER, A. J., REISINE, S. T., AFFLECK, G., BARROWS, E., & ZuWALLACK, R. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9712007 · Cited by 381
The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending
Huskamp, H. A., Deverka, P. A., Epstein, A. M., Epstein, R. S., McGuigan, K. A., & Frank, R. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa030954 · Cited by 334
Ellis, J. J., Erickson, S. R., Stevenson, J. G., Bernstein, S. J., Stiles, R. A., & Fendrick, A. M. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30516.x · Cited by 323
Metered-Dose Inhaler Adherence in a Clinical Trial
Rand, C. S., Wise, R. A., Nides, M., Simmons, M. S., Bleecker, E. R., Kusek, J. W., Li, V. C., & Tashkin, D. P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.6.1559 · Cited by 302
Monane, M. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00056-3 · Cited by 276
Apter, A. J., Boston, R. C., George, M., Norfleet, A. L., Tenhave, T., Coyne, J. C., Birck, K., Reisine, S. T., Cucchiara, A. J., & Feldman, H. I. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1479 · Cited by 269
Employer Drug Benefit Plans and Spending on Prescription Drugs
Joyce, G. F. (2002) · JAMA · doi:10.1001/jama.288.14.1733 · Cited by 228
Gender differences in factors associated with adherence to antiretroviral therapy
Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N., & Arnsten, J. H. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30445.x · Cited by 213
Powerful medicines: the benefits, risks, and costs of prescription drugs
(2005) · Choice Reviews Online · doi:10.5860/choice.42-5297a · Cited by 191
Using aggregate geographic data to proxy individual socioeconomic status: does size matter?
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.4.632 · Cited by 189
Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors
Schneeweiss, S., Walker, A. M., Glynn, R. J., Maclure, M., Dormuth, C., & Soumerai, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa003087 · Cited by 178
Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization
Motheral, B., & Fairman, K. A. (2001) · Medical Care · doi:10.1097/00005650-200112000-00005 · Cited by 161
Who Bears The Burden Of Medicaid Drug Copayment Policies?
Stuart, B., & Zacker, C. (1999) · Health Affairs · doi:10.1377/hlthaff.18.2.201 · Cited by 153
Financial Incentives And Drug Spending In Managed Care
Hillman, A. L., Pauly, M. V., Escarce, J. J., Ripley, K., Gaynor, M., Clouse, J., & Ross, R. (1999) · Health Affairs · doi:10.1377/hlthaff.18.2.189 · Cited by 137
The problem of compliance to cholesterol altering therapy
Insull, W. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.112133000.x · Cited by 121
The differential impact of copayment on drug use in a Medicaid population.
Reeder, C. E., & Nelson, A. A. (1985) · PubMed · Cited by 111
Compliance with prescribed drug therapy in asthma
Yeung, M., O'Connor, S. A., Parry, D., & Cochrane, G. M. (1994) · Respiratory Medicine · doi:10.1016/0954-6111(94)90171-6 · Cited by 91
Objective measurements of compliance in asthma treatment.
Chmelik, F., & Doughty, A. (1994) · PubMed · Cited by 86
Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications
Rector, T. S., Finch, M. D., Danzon, P. M., et al. (2003) · Medical Care · doi:10.1097/01.mlr.0000053022.47132.82 · Cited by 85
Patient Noncompliance in the Managed Care Setting
Gurwitz, J. H., Yeomans, S. M., Glynn, R. J., Lewis, B. E., Levin, R., & Avorn, J. (1998) · Medical Care · doi:10.1097/00005650-199803000-00012 · Cited by 76
Self-citationThe effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith, D. G. (1993) · PubMed · Cited by 73
Nair, K. V., Wolfe, P., Valuck, R. J., et al. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.5.575 · Cited by 42
Self-citationThree-Tiered–Copayment Drug Coverage and Use of Nonsteroidal Anti-inflammatory Drugs
Briesacher, B. A., Kamal‐Bahl, S. J., Hochberg, M. C., Orwig, D., & Kahler, K. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1679 · Cited by 29
Compliance with antihypertensive therapy: raising the bar of expectations.
Rudd, P. (1998) · PubMed · Cited by 28
Are Incentive-Based Formularies Inversely Associated with Drug Utilization in Managed Care?
Gleason, P. P., Gunderson, B. W., & Gericke, K. R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e380 · Cited by 21
Cited by
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform
Kesselheim, A. S., Avorn, J., & Sarpatwari, A. (2016) · JAMA · doi:10.1001/jama.2016.11237 · Cited by 592
Self-citationPrimary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
Fischer, M. A., Stedman, M. R., Lii, J., Vogeli, C., Shrank, W. H., Brookhart, M. A., & Weissman, J. S. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1253-9 · Cited by 572
Self-citationMedication adherence: a call for action
Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, S. M., Daniel, J. G., Ekman, I., Ho, M., Johnson, M., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.007 · Cited by 448
Kesselheim, A. S. (2008) · JAMA · doi:10.1001/jama.2008.758 · Cited by 431
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending
WOUTERS, O. J., KANAVOS, P. G., & McKEE, M. (2017) · The Milbank Quarterly · doi:10.1111/1468-0009.12279 · Cited by 287
Metadata
- Authors
- Shrank, W. H., Hoang, T., Ettner, S. L., Glassman, P. A., Nair, K., DeLapp, D., Dirstine, J., Avorn, J., & Asch, S. M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-02-13
- Volume
- 166
- Issue
- 3
- Pages
- 332
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2067032911
- Cited by
- 343
- References
- 33
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.